• X
  • LinkedIn
  • Email
  • Show more sharing options
  • X
  • LinkedIn
  • Email
  • Free trial
  • Log in

Search results for

Tip: Use operators exact match "", AND, OR to customise your search. You can use them separately or you can combine them to find specific content.
There are 68,928 results that match your search.68,928 results
  • Relative newcomer Torus's withdrawal from the excess liability market in March was hastened by last year's heavy loss experience in the segment, sources suggest
  • Amlin's Dutch CEO walks; Gryphon loss ups to $800mn; MMC in boardroom reshuffle; Albers heads new Swiss Re arm; Munich Re suspends buybacks...
  • Nuclear leads Lloyd's top performers; RK Harrison profits dip; Brit squeeze-out begins; Atrium merges on Wilkins exit; Advisen Connects...
  • BP has asked a Texas judge to dismiss a lawsuit filed by some institutional investors, claiming the UK High Court should hear the case
  • A roll-call of stateside insurers and brokers agreed to pay $36.8mn in March to settle a long-running Eliot Spitzer-inspired lawsuit that claimed the companies engaged in bid-rigging
  • US broker AmWins has settled the lawsuit it brought last year against Pat Ryan's wholesale start-up RT Specialty that alleged "misappropriation of trade secrets" after the defection of one of its senior brokers
  • The UK Financial Services Authority (FSA) has confirmed its budget for the financial year 2011/12 will increase by just over 10 percent to £500.5mn
  • UK corporation tax will be cut by 2 percent this year, as the government outlined its plans to boost growth in a budget that tax advisers instantly hailed as good for insurers
  • The regulatory cost for brokers in the UK is three times higher than for rivals in the second most expensive European state, new research by the British Insurance Brokers Association (Biba) has revealed
  • The European Insurance and Occupational Pensions Authority (Eiopa) will conduct a second industry-wide stress test to assess participants' vulnerability to a range of potential adverse developments